anserine has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Cheng, T; Deng, X; Hao, L; Lin, C; Ou, Y; Xiong, T | 1 |
| Hisatsune, T; Inamura, N; Lei, C; Li, H; Masuoka, N; Sakurai, K; Sato, K; Shiotani, S; Yanai, N | 1 |
1 trial(s) available for anserine and Disease Exacerbation
| Article | Year |
|---|---|
Anserine, HClO-scavenger, protected against cognitive decline in individuals with mild cognitive impairment.
Topics: Aged; Anserine; Antioxidants; Cognition; Cognitive Dysfunction; Disease Progression; Double-Blind Method; Female; Humans; Male; Neuropsychological Tests | 2021 |
1 other study(ies) available for anserine and Disease Exacerbation
| Article | Year |
|---|---|
Anserine bursa palpation tenderness is a risk factor for knee osteoarthritis progression and arthroplasty: data from the Osteoarthritis Initiative.
Topics: Aged; Anserine; Arthroplasty, Replacement, Knee; Disease Progression; Female; Humans; Knee Joint; Middle Aged; Osteoarthritis, Knee; Pain; Palpation; Risk Factors | 2023 |